Keros Therapeutics Inc. (KROS)
NASDAQ · Healthcare
Keros Therapeutics Inc. Income Statement 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenue | 244.1M | 3.5M | 151,000 | 0 | 20.1M | 0 | 10.0M |
| Gross Profit | — | — | — | — | — | — | — |
| Profitability | |||||||
| Operating Income | 67.6M | -210.8M | -169.9M | -114.8M | -56.4M | -46.7M | -10.6M |
| EBITDA | — | — | — | — | — | — | — |
| Net Income | 87.0M | -187.4M | -153.0M | -104.7M | -58.7M | -45.4M | -12.3M |
| Per Share Data | |||||||
| EPS (diluted) | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 38M | 37M | 29M | 25M | 23M | 16M | 2M |
Keros Therapeutics Inc. Income Statement — FAQ
Keros Therapeutics Inc. (KROS) income statement over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KROS's income statement history?
The chart and table above show Keros Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.